New Zealand independent advisers
H2 2026 to date · Independent adviser reports on deals announced to 10 Nov 2026 · 1 deal
Columns
Every deal that counts towards this table, with the firms credited on it. Tick deals to leave them out of the ranking or to rank only those deals; the page then says the ranking is a custom view.
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2026 | Rekover Therapeutics | Tenmile | Invex Therapeutics | Acquisition | – | Announced | Biotech and pharmaceuticals | Moore Australia (buy-side) | Invex Therapeutics acquisition of Rekover Therapeutics |
1 deal has no disclosed value. H2 2025 rank is the firm's place in the same period a year earlier, under the same filters. Methodology